Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Five Clinical Trial Hits Of 2023

Jan 05 2024

• By Alexandra Shimmings

target — • Source: Shutterstock

Related Content

Karuna Three-For-Three As Another KarXT Schizophrenia Trial Hits Primary Endpoint

Mar 20 2023

Dupixent Heralds The Age Of Biologics In COPD

Nov 27 2023

BMS Speeds Expansion Into Neuroscience With $14bn Karuna Buy

Dec 22 2023

Lilly’s Donanemab, Now At FDA, Poised To Join Alzheimer’s Armamentarium

Jul 17 2023

The FLOW Of Novo Nordisk's Semaglutide Success Rolls Into Kidney Disease

Oct 11 2023

Novo Nordisk STEPs Into Heart Failure

Aug 25 2023

AHA 2023 – Wegovy Cuts Death Risk, But Will That Be Enough For Payers?

Nov 11 2023

ESMO 23: Madrid Meeting Hails Padcev/Keytruda Combo As New Bladder Cancer Standard Of Care

Oct 23 2023

Related Companies

Sanofi

Regeneron Pharmaceuticals, Inc.

Eli Lilly and Company

Karuna Therapeutics, Inc.

Additional Topics

Clinical Trials Companies Research & Development Scrip Perspectives Cancer Metabolic Disorders Respiratory Neurology Cardiovascular BioPharmaceutical

More from Scrip Perspectives

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window